Your session is about to expire
← Back to Search
Cancer Risk Assessment for Hereditary Cancer Risk
Study Summary
This trial will compare three methods for identifying and risk-stratifying individuals at risk of hereditary cancer, and providing post-risk stratification longitudinal care.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been a member for over 2 years, visited the clinic in the last 2 years, and have an email listed.
- Group 1: Comparator 1
- Group 2: Comparator 2
- Group 3: Comparator 3
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being included in this clinical experiment?
"Affirmative. As indicated on clinicaltrials.gov, the recruitment process for this trial has been ongoing since July 1st 2020 and most recently updated in October 19th 2021. 18000 participants need to be enrolled at one centre."
Is enrollment for this research project still accessible to participants?
"According to the clinicaltrials.gov portal, this trial is actively searching for participants. The original posting date was July 1st 2020 and it has been edited most recently on October 19th 2021."
Are individuals over the age of 50 eligible for enrollment in this clinical trial?
"Participants aged between 25 and 75 years old are sought for this clinical trial."
Am I an eligible candidate for this research program?
"To meet the prerequisites of admission, those interested must possess Lynch Syndrome and be between the ages of 25 to 75. The trial is aiming to recruit 18000 participants in total."
Share this study with friends
Copy Link
Messenger